RECTAL CANCER RECURRENT

This adverse event was reported 85 times

These drugs are most commonly taken by patients reporting RECTAL CANCER RECURRENT:

# Drug Count
0 BEVACIZUMAB 22
1 OXALIPLATIN 20
2 CAPECITABINE 16
3 FLUOROURACIL 13
4 FLUOROURACIL CREAM, 0.5% 13
5 PANITUMUMAB 7
6 REGORAFENIB 6
7 CETUXIMAB 5
8 ADALIMUMAB 4
9 HYDROCHLOROTHIAZIDE 4
See all common drugs associated with RECTAL CANCER RECURRENT

RECTAL CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LANOLIN, PETROLATUM 1 0.0040
1 LANOLIN AND PETROLATUM 1 0.0038
2 LIDOCAINE AND PRILOCAINE 1 0.0007
3 WHITE PETROLATUM 1 0.0007
4 FLURBIPROFEN 1 0.0007
5 LEVOLEUCOVORIN INJECTION 2 0.0007
6 CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE 2 0.0006
7 LEVOLEUCOVORIN 2 0.0005
8 REGORAFENIB 6 0.0005
9 FRUQUINTINIB 2 0.0005
See all drugs enriched for association with RECTAL CANCER RECURRENT